affiliate disclosure · we earn commission on some vendor links. audits, scores, and rankings are independent — vendors do not pay for placement. read more →
Is Mochi Health legit?
Mochi Health is operating and surfaces credible public signals (composite 64/100), but we have not placed a first-hand consult yet — this is a public-data audit. Membership-based 503A telehealth platform led by board-certified obesity-medicine physicians. Highest prescriber-credentialing signal in our v0 pharmacy cohort. Sits on the same post-shortage personalization-pathway regulatory cloud as Hims and Henry Meds. The signal table below shows what we verified and what is still open. Read the full audit for FDA history, state-board records, and licensure footprint.
Signal table
WHAT WE VERIFIEDWhat works, what does not
AUDIT SUMMARY- Founded by Dr. Myra Ahmad, board-certified in obesity medicine. The named-provider page lists credentialed physicians with their ABOM / board status visible - significantly stronger prescriber-transparency signal than Hims or Henry Meds
- Pediatric obesity-medicine vertical (rare in the cohort - Hims, Henry, and the others focus exclusively on adult care)
- Insurance-friendly framing - accepts commercial insurance for the medication path (Hims and Henry are cash-only)
- Substantial press coverage in mainstream outlets (USA Today, Business Insider, CNBC, WSJ, Forbes, NPR, Wired, NY Post) - more press footprint than any other vendor in the cohort
- Membership model separates the platform fee ($79/mo, $39 promo first-month) from medication cost, which is a cleaner price-transparency posture than bundled-subscription competitors
- Affiliated and in-house dispensing pharmacy network referenced in site navigation
- Membership-fee + medication-cost split adds checkout complexity. A buyer comparing total monthly cost to Hims or Henry needs to read both numbers
- The same FDA personalization-pathway regulatory cloud that defines the cohort applies equally to Mochi. The obesity-specialist physician model strengthens the "clinical-need personalization" defense (specialist diagnosis is documentable) but does not eliminate the structural regulatory question
- Private company - no SEC disclosure regime, so audited financials and earnings-call FDA correspondence are not in the verifiable record
- The per-fill dispensing pharmacy is not disclosed at checkout in the public-data pass we ran
- API (active pharmaceutical ingredient) sourcing dossier is not publicly disclosed at the upstream-manufacturer level
- Pediatric care expansion is editorially noteworthy but increases the per-fill regulatory exposure because pediatric compounded GLP-1 is a more sensitive use-case than adult care
What we mean by “legit”
SCORING SPINEFor a 503A compounding pharmacy, "legit" is not a single yes-or-no signal. The composite is a weighted average across nine dimensions — state pharmacy licensure footprint, FDA inspection history, state-board enforcement, USP <797> sterility signals, prescriber quality, raw-material sourcing, price transparency, buyer experience, and buyer protection. Read the full rubric at /methodology/compounding.
For Mochi Health the audit is "public-data tier" — we aggregate pharmacy disclosures, FDA databases, state-board records, NPI registry data, and community signals. A first-hand consult is pending and this page will be upgraded when that lands.
Frequently asked
6 QUESTIONSIs Mochi Health legit?
Mochi Health is operating and surfaces credible public signals (composite 64/100), but we have not placed a first-hand consult yet — this is a public-data audit. Membership-based 503A telehealth platform led by board-certified obesity-medicine physicians. Highest prescriber-credentialing signal in our v0 pharmacy cohort. Sits on the same post-shortage personalization-pathway regulatory cloud as Hims and Henry Meds. The signal table below shows what we verified and what is still open. Read the full audit for FDA history, state-board records, and licensure footprint.
Is Mochi Health a real pharmacy?
Mochi Health operates a hybrid model — it both dispenses directly and routes some prescriptions to partner pharmacies. The legal entity is Mochi Health, Inc..
What states is Mochi Health licensed in?
Mochi Health serves all 50 states. You can confirm any state's licensure directly through that state's Board of Pharmacy license-lookup tool.
Has Mochi Health had any FDA inspections?
No FDA actions are on record (public databases as of 2026-05-29) for Mochi Health. Absence of a 483 or warning letter is not the same as a sterility audit — the FDA inspects 503A pharmacies on a complaint-driven and risk-based cycle, not annually.
Has vialaudit placed a consult with Mochi Health?
Not yet. Mochi Health is currently a public-data audit. We aggregate pharmacy disclosures, FDA inspection databases, state-board enforcement records, NPI registry data, and community signals. A first-hand consult is pending — this page upgrades when that lands.
How does Mochi Health compare to other compounding pharmacies?
Mochi Health's composite is 64/100. The composite is weighted across nine dimensions — licensure, FDA history, state enforcement, sterility, prescriber, sourcing, price transparency, buyer experience, and buyer protection. See /pharmacies for the full leaderboard and /methodology/compounding for the rubric.
Verdict
READ FULL AUDIT →Other audited pharmacies
IS IT LEGIT?Sources
9 CITED- Mochi Health homepage — vendor
- Mochi Health providers page — vendor
- Mochi Health pharmacy page — vendor
- FDA - Compounding under section 503A of the Federal Food, Drug, and Cosmetic Act — FDA
- FDA - Compounding inspections, recalls, and other actions — FDA
- Mochi Health - Trustpilot profile — Trustpilot
- r/tirzepatidecompound May 2026 telehealth & pharmacy survey — Reddit community survey
- vialaudit - Compounded semaglutide in 2026 status read — vialaudit
- vialaudit - 503A and the PCAC GLP-1 compounding article — vialaudit